CoChat

Harnessing metabolic dependencies in pancreatic cancers

Open access
Encarnación-Rosado, Joel, Kimmelman, Alec C. · 2021 · Nature Reviews Gastroenterology & Hepatology
Cited by 174

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease with a 5-year survival rate of <10%. The tumour microenvironment (TME) of PDAC is characterized by excessive fibrosis and deposition of extracellular matrix, termed desmoplasia. This unique TME leads to high interstitial pressure, vascular collapse and low nutrient and oxygen diffusion. Together, these factors contribute to the unique biology and therapeutic resistance of this deadly tumour. To thrive in this hostile environment, PDAC cells adapt by using non-canonical metabolic pathways and rely on metabolic scavenging pathways such as autophagy and macropinocytosis. Here, we review the metabolic pathways that PDAC use to support their growth in the setting of an austere TME. Understanding how PDAC tumours rewire their metabolism and use scavenging pathways under environmental stressors might enable the identification of novel therapeutic approaches. Pancreatic ductal adenocarcinoma (PDAC) has a unique tumour microenvironment. Notably, PDAC can reprogramme metabolism in response to this microenvironment. This Review discusses metabolism in pancreatic cancer, including insights into mechanisms and processes as well as the potential therapeutic applications. Pancreatic ductal adenocarcinoma (PDAC) is characterized by hypoxia, low nutrient levels, high interstitial pressure and desmoplasia. To survive and thrive in this hostile environment, PDAC cells reprogramme their metabolism. PDAC cells also utilize lysosomal scavenging pathways (for example, autophagy and macropinocytosis) to support and maintain metabolic homeostasis. Other cellular populations present in the tumour microenvironment of PDAC, such as cancer-associated fibroblasts, neurons and immune cells, can support PDAC growth under nutrient-limiting conditions. Targeting the metabolic vulnerabilities of PDAC could provide new therapeutic interventions. Pancreatic ductal adenocarcinoma (PDAC) is characterized by hypoxia, low nutrient levels, high interstitial pressure and desmoplasia. To survive and thrive in this hostile environment, PDAC cells reprogramme their metabolism. PDAC cells also utilize lysosomal scavenging pathways (for example, autophagy and macropinocytosis) to support and maintain metabolic homeostasis. Other cellular populations present in the tumour microenvironment of PDAC, such as cancer-associated fibroblasts, neurons and immune cells, can support PDAC growth under nutrient-limiting conditions. Targeting the metabolic vulnerabilities of PDAC could provide new therapeutic interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41575-021-00431-7

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Cited by

See all 174

Metadata

Authors
Encarnación-Rosado, J., & Kimmelman, A. C.
Venue
Nature Reviews Gastroenterology & Hepatology
Published
2021-03-19
Volume
18
Issue
7
Pages
482-492
ISSN
  • 1759-5045 (ISSN-L)
  • 1759-5053
OpenAlex
W3139344827
Cited by
174
References
77
FWCI
4.49
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Harnessing metabolic dependencies in pancreatic cancers. https://app.cochat.ai/papers/10.1038/s41575-021-00431-7
The paper
Encarnación-Rosado, J., & Kimmelman, A. C. (2021). Harnessing metabolic dependencies in pancreatic cancers. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-021-00431-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.